Clinical Trial Eligibility Criteria: What They Mean

Eligibility criteria are inclusion and exclusion rules covering factors such as cancer type and stage, prior treatments, specific biomarkers, overall health status, organ function, and sometimes age. Inclusion criteria describe who the trial is designed for, while exclusion criteria rule out factors that could make participation unsafe or interfere with study results.

Understanding eligibility criteria helps you and your oncologist identify realistic trial options and avoid the disappointment of applying to trials you're unlikely to qualify for. It also highlights which additional tests, such as genetic profiling, might open up more options.

The screening process typically reviews existing medical records first, then may add specific tests like genomic profiling, cardiac assessments, or updated scans requested solely for the trial. Results are compared against the trial's published inclusion and exclusion list.

Eligibility criteria vary widely by cancer type and trial design; biomarker-driven trials in lung, breast, or colorectal cancer may require specific genetic mutations, while trials in rare cancers may have broader criteria to allow enough patients to enrol. Trials for advanced or relapsed cancers often specify how many prior treatment lines a patient may have had.

If eligible, participation may require stopping certain current medications for a washout period, travelling to a specific trial site, and attending a defined visit schedule. Discuss with your oncology team how the trial's requirements would fit around your existing treatment and daily life.